Overall Status

Completed (2)

Recruiting (1)

Phase

n/a (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

AdventHealth (1)

Asociacion de Oncologia Medica del Hospital de Cruces (1)

Memorial Sloan Kettering Cancer Center (1)

Collaborator

Apices Soluciones S.L. (1)

Celgene (1)

Intervention

celiac plexus neurolysis (1)

gemcitabine 1000 weeks 1,2,3/4 (1)

nab-paclitaxel 125 mg/m2 weeks 1,2,3/4 (1)

pertzye (1)

radiofrequency ablation (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Other (3)

Study Type

Interventional (3)

pancreatic carcinoma metastatic

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

Recruiting

Metastatic Pancreatic Ductal Adenocarcinoma
+12 more

Pertzye

New York, New York

Memorial Sloan Kettering Cancer Center

Nov 30, 2022

Pancreatic Carcinoma Metastatic Trial in Spain (Nab-paclitaxel 125 mg/m2 weeks 1,2,3/4, Gemcitabine 1000 weeks 1,2,3/4)

Completed

Pancreatic Carcinoma Metastatic

Nab-paclitaxel 125 mg/m2 weeks 1,2,3/4
Gemcitabine 1000 weeks 1,2,3/4

Granollers, Barcelona, Spain
+20 more

Aug 26, 2019

Pancreatic Carcinoma Metastatic, Pancreatic Adenocarcinoma, Pancreatic Tumors Trial in Orlando (Celiac Plexus Neurolysis,

Completed

Pancreatic Carcinoma Metastatic
+4 more

Celiac Plexus Neurolysis
Radiofrequency Ablation

Orlando, Florida

Center for Interventional Endoscopy - Florida Hospital

Feb 8, 2019